Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver

Journal of Immunology

Volumn 168, Issue 5, 2002, Pages 2188-2199

  Watanabe, Tomohiro ^a   Yoshida, Masaru ^a   Shirai, Yasuhiko ^a   Yamori, Masashi ^a   Yagita, Hideo ^a   Itoh, Toshiyuki ^a   Chiba, Tsutomu ^a   Kita, Toru ^a   Wakatsuki, Yoshio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; OVALBUMIN; STAPHYLOCOCCUS ENTEROTOXIN B; TRANSFORMING GROWTH FACTOR BETA1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MEGADOSE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0036498794     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.5.2188     Document Type: Article

References (45)

1. Strange brew: T cells in the liver
2. Prometheus through the looking glass: Reflections on the hepatic immune system
3. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen
4. + T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells
5. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats
6. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance
7. A strategy for organ allografts without using immunosuppressants or irradiation
8. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection
9. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
10. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
11. Effects of oral administration of type II collagen on rheumatoid arthritis
12. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis
13. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
14. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation
15. Peripheral deletion of antigen-reactive T cells in oral tolerance
16. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding
17. Bacterial and dietary antibodies in liver disease
18. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage
19. A subset of γδ T-cell receptor-positive cells produce T-helper type-2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization
20. + T cells results in antigen-specific T-cell tolerance
21. lo thymocytes in vivo
22. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
23. Preparation of cell suspensions from spleen, thymus, and lymph node
24. Isolation of PP lymphocytes
25. + T cells triggered by high affinity peptide antigens
26. Essential requirement of an invariant Vα14 T cell antigen receptor expression in the development of natural killer T cells
27. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype
28. Polymorphism of murine Fas ligand that affects the biological activity
29. T cell growth factor: Parameters of production and a quantitative microassay for activity
30. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S)
31. IL-4 and IL-10 are both required for the induction of oral tolerance
32. The JAM test: A simple assay for DNA fragmentation and cell death
33. The B cell-specific transcription factor BSAP regulates B cell proliferation
34. Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization
35. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo
36. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo
37. + T cells by the normal liver
38. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity in vivo
39. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis
40. Differential ability of T cell subsets to undergo activation-induced cell death
41. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: Stat6 is probably not required for the effect of IL-4
42. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells
43. + T cells are present within a population of intermediate TCR cells
44. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model
45. - T cells in mice and humans